Vor Biopharma Inc Market Cap ($1.13 Billion)
Market Cap & Net Worth: Vor Biopharma Inc (VOR)
Vor Biopharma Inc market cap. Vor Biopharma Inc (NASDAQ:VOR) has a market capitalization of $1.13 Billion ($1.13 Billion) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8077 globally and #2415 in its home market, demonstrating a 8.35% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vor Biopharma Inc's stock price $19.86 by its total outstanding shares 59162294 (59.16 Million). Also see Vor Biopharma Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Vor Biopharma Inc Market Cap History (2021–2026)
Vor Biopharma Inc market cap history from 2021 to 2026. Data shows change from $687.47 Million to $1.17 Billion (-10.47% CAGR). Check Vor Biopharma Inc stock price for real-time trading data and today's change.
Index Memberships
Vor Biopharma Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.04% | #236 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #893 of 3165 |
Weight: Vor Biopharma Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vor Biopharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vor Biopharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Vor Biopharma Inc annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VOR by Market Capitalization
Companies near Vor Biopharma Inc in the global market cap rankings as of November 5, 2026. Also see VOR total assets for a full breakdown of the balance sheet.
Key companies related to Vor Biopharma Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Vor Biopharma Inc (2021–2026)
Market capitalization of Vor Biopharma Inc from 2021 to today. Between 2021 and today, Vor Biopharma Inc's market cap moved from $687.47 Million to $ 1.17 Billion, with a yearly change of -10.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.17 Billion | +51.83% |
| 2025 | $773.84 Million | +1078.38% |
| 2024 | $65.67 Million | -50.67% |
| 2023 | $133.12 Million | -66.17% |
| 2022 | $393.43 Million | -42.77% |
| 2021 | $687.47 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Vor Biopharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.13 Billion USD |
| MoneyControl | $1.13 Billion USD |
| MarketWatch | $1.13 Billion USD |
| marketcap.company | $1.13 Billion USD |
| Reuters | $1.13 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vor Biopharma Inc
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with Re… Read more